All stock lists
Unlock the score
Attovia Therapeutics, Inc. (NASDAQ:ATTO)
US · Delayed Price · Currency is USD
Healthcare · Biotechnology
13.84+0.01 (+0.07%)
Insider Score
/ 100
ATTO Insider Score
Attovia Therapeutics, Inc. has a live Insider Score.
Scored on 4 qualifying trades from 1 insider in the last 90 days.
ATTO Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Jun 30, 2025 | Mar 31, 2025 |
| Revenue | 450.00 K | 0.00 | 0.00 | 0.00 |
| Revenue Growth (YoY) | — | — | — | — |
| Cost of Revenue | 246.00 K | 242.00 K | 0.00 | 143.00 K |
| Gross Profit | 204.00 K | -242.00 K | 0.00 | -143.00 K |
| SG&A Expense | 3.06 M | 2.97 M | 3.03 M | 4.11 M |
| R&D Expense | 18.95 M | 16.75 M | 13.59 M | 11.86 M |
| Operating Expenses | 22.01 M | 19.71 M | 16.62 M | 15.96 M |
| Operating Income | -21.80 M | -19.95 M | -16.62 M | -16.10 M |
| Pretax Income | -20.69 M | -18.66 M | -14.44 M | -15.15 M |
| Tax Provision | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income | -20.69 M | -18.66 M | -14.44 M | -15.15 M |
| EPS (Basic) | -0.45 | -0.48 | -0.56 | -0.40 |
| EPS (Diluted) | -0.45 | -0.48 | -0.56 | -0.40 |
| Shares Outstanding | 45.65 M | 38.53 M | 25.67 M | 38.53 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.